These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 16260599)
1. A novel mitogen-activated protein kinase docking site in the N terminus of MEK5alpha organizes the components of the extracellular signal-regulated kinase 5 signaling pathway. Seyfried J; Wang X; Kharebava G; Tournier C Mol Cell Biol; 2005 Nov; 25(22):9820-8. PubMed ID: 16260599 [TBL] [Abstract][Full Text] [Related]
2. PB1 domain-dependent signaling complex is required for extracellular signal-regulated kinase 5 activation. Nakamura K; Uhlik MT; Johnson NL; Hahn KM; Johnson GL Mol Cell Biol; 2006 Mar; 26(6):2065-79. PubMed ID: 16507987 [TBL] [Abstract][Full Text] [Related]
4. Noncanonical function of MEKK2 and MEK5 PB1 domains for coordinated extracellular signal-regulated kinase 5 and c-Jun N-terminal kinase signaling. Nakamura K; Johnson GL Mol Cell Biol; 2007 Jun; 27(12):4566-77. PubMed ID: 17452462 [TBL] [Abstract][Full Text] [Related]
5. PB1 domains of MEKK2 and MEKK3 interact with the MEK5 PB1 domain for activation of the ERK5 pathway. Nakamura K; Johnson GL J Biol Chem; 2003 Sep; 278(39):36989-92. PubMed ID: 12912994 [TBL] [Abstract][Full Text] [Related]
6. Differential role of MEK5alpha and MEK5beta in BMK1/ERK5 activation. Cameron SJ; Abe J; Malik S; Che W; Yang J J Biol Chem; 2004 Jan; 279(2):1506-12. PubMed ID: 14583600 [TBL] [Abstract][Full Text] [Related]
7. MEKK2 associates with the adapter protein Lad/RIBP and regulates the MEK5-BMK1/ERK5 pathway. Sun W; Kesavan K; Schaefer BC; Garrington TP; Ware M; Johnson NL; Gelfand EW; Johnson GL J Biol Chem; 2001 Feb; 276(7):5093-100. PubMed ID: 11073940 [TBL] [Abstract][Full Text] [Related]
10. HB-EGF induces cardiomyocyte hypertrophy via an ERK5-MEF2A-COX2 signaling pathway. Lee KS; Park JH; Lim HJ; Park HY Cell Signal; 2011 Jul; 23(7):1100-9. PubMed ID: 21244855 [TBL] [Abstract][Full Text] [Related]
11. Homogeneous time-resolved fluorescence resonance energy transfer assay for measurement of Phox/Bem1p (PB1) domain heterodimerization. Nakamura K; Zawistowski JS; Hughes MA; Sexton JZ; Yeh LA; Johnson GL; Scott JE J Biomol Screen; 2008 Jun; 13(5):396-405. PubMed ID: 18480472 [TBL] [Abstract][Full Text] [Related]
12. Targeted deletion of mek5 causes early embryonic death and defects in the extracellular signal-regulated kinase 5/myocyte enhancer factor 2 cell survival pathway. Wang X; Merritt AJ; Seyfried J; Guo C; Papadakis ES; Finegan KG; Kayahara M; Dixon J; Boot-Handford RP; Cartwright EJ; Mayer U; Tournier C Mol Cell Biol; 2005 Jan; 25(1):336-45. PubMed ID: 15601854 [TBL] [Abstract][Full Text] [Related]
13. Insight into the binding properties of MEKK3 PB1 to MEK5 PB1 from its solution structure. Hu Q; Shen W; Huang H; Liu J; Zhang J; Huang X; Wu J; Shi Y Biochemistry; 2007 Nov; 46(47):13478-89. PubMed ID: 17985933 [TBL] [Abstract][Full Text] [Related]
15. MEK5/ERK5/mef2: a novel signaling pathway affected by hepatitis C virus non-enveloped capsid-like particles. Katsarou K; Tsitoura P; Georgopoulou U Biochim Biophys Acta; 2011 Oct; 1813(10):1854-62. PubMed ID: 21767578 [TBL] [Abstract][Full Text] [Related]
16. Effects of MEK5/ERK5 association on small ubiquitin-related modification of ERK5: implications for diabetic ventricular dysfunction after myocardial infarction. Shishido T; Woo CH; Ding B; McClain C; Molina CA; Yan C; Yang J; Abe J Circ Res; 2008 Jun; 102(11):1416-25. PubMed ID: 18467627 [TBL] [Abstract][Full Text] [Related]
17. MEF2C regulates c-Jun but not TNF-alpha gene expression in stimulated mast cells. Wei X; Sun W; Fan R; Hahn J; Joetham A; Li G; Webb S; Garrington T; Dakhama A; Lucas J; Johnson GL; Gelfand EW Eur J Immunol; 2003 Oct; 33(10):2903-9. PubMed ID: 14515274 [TBL] [Abstract][Full Text] [Related]
18. MEK5 and ERK5 are localized in the nuclei of resting as well as stimulated cells, while MEKK2 translocates from the cytosol to the nucleus upon stimulation. Raviv Z; Kalie E; Seger R J Cell Sci; 2004 Apr; 117(Pt 9):1773-84. PubMed ID: 15075238 [TBL] [Abstract][Full Text] [Related]
19. Activation of either ERK1/2 or ERK5 MAP kinase pathways can lead to disruption of the actin cytoskeleton. Barros JC; Marshall CJ J Cell Sci; 2005 Apr; 118(Pt 8):1663-71. PubMed ID: 15797923 [TBL] [Abstract][Full Text] [Related]
20. Identification of pharmacological inhibitors of the MEK5/ERK5 pathway. Tatake RJ; O'Neill MM; Kennedy CA; Wayne AL; Jakes S; Wu D; Kugler SZ; Kashem MA; Kaplita P; Snow RJ Biochem Biophys Res Commun; 2008 Dec; 377(1):120-5. PubMed ID: 18834865 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]